Sex determination using sex determining region Y primers by single conventional polymerase chain reaction by Pakravan, N. et al.
Albumin. Its place in critical care
practice  
Mariam A. Al-Ansari, MD, FRCSI.
ost critically ill patients have a common
pathophysiological process. Infection, trauma,
or major surgery initiates an inflammatory cascade
leading to the release of various inflammatory
mediators (for example, cytokines) and activation of
leukocytes. This is a self-perpetuating cascade,
which results in damaged endothelial integrity,
increasing microvascular permeability and promotes
extravasations of fluids (including albumin) into the
tissue. Moreover, there are several reasons why
albumin supplementation might make things worse
for critically ill patients.1 Cost containment is
becoming an increasingly important factor in
medical decision making. Human albumin solutions
are more expensive than other colloids and
crystalloids. An acceptable alternative to albumin
would be favorable. The impact of albumin infusion
on survival has long been a subject of debate and
several investigations. It is very difficult to
comment on the rational of use of albumin in
clinical practice. Variations in patients, targets,
additive therapy, and other factors make
interpretation of the literature difficult. Interestingly,
despite advice not to use albumin, use of this
product continues. There is no convincing data
justifying administration of albumin either for
treating hypovolemia or for correcting hypo-
albuminemia. In this report, we will summarize
what the literature states on the use of albumin for
the critically ill patient.
Despite a growing body of systematic reviews
and evidence based medicine analyses, the safety
profile of albumin is still under dispute. Two meta-
analysis of randomized trials have broadly assessed
the effects of albumin on survival.2,3 None showed a
significant overall survival benefit. Indeed, the
Cochrane Injuries Group Albumin Reviewers meta-
analyses even indicated increased mortality amongst
albumin recipients (6.8%). A major limitation of
both meta-analyses is the reliance on survival as the
end point. More than half of the included
randomized trials were not designed to assess this
end point. Another meta-analysis ncluded only
studies using purified albumin and a wide spectrum
of patients. It included 55 trials involving 3,504
patients. Overall, this analysis detected no
difference in mortality between patients treated with
albumin and other fluids.4 A more recent systematic
review included 79 randomized trials with a total of
4,755 patients.5 It showed definite beneficial effects
of albumin in both cardiac and non cardiac surgery.
M
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They analyzed the use of albumin administration in
diverse clinical settings, such as hypoalbuminemia,
ascites, sepsis, burn patients and outcomes after
brain injury. They concluded that albumin does
bestow benefit in terms of decreased morbidity in a
wide array of clinical settings. However, the optimal
dose and administration schedule for albumin
remain to be delineated. Further investigations are
warr nted to address these issues.
The Saline versus Albumin Fluid Evaluation
(SAFE) study is the largest ever multicentric,
double blind, randomized controlled trial of SAFE
for fluid resuscitation of critically ill patients in
intensive care from 16 intensive care units in
Australia and New Zealand over an 18 month
period. Of the 6,997 patients who underwent
randomization, 3,497 were assigned to receive 4%
albumin and 3,500 to receive saline.6 There were
726 deaths in the albumin group compared to 729
deaths in the saline group (relative risk of death,
0.99; 95% confidence interval: 0.91-1.09; p=0.87).
The 2 groups of patients had a similar proportion of
new single-organ and multiple-organ failure
(p=0.85). There were no significant differences
between the groups in the mean numbers of days
spent in the ICU, days spent in the hospital, days of
mechanical ventilation, or days of renal-replacement
therapy. Subgroup analysis of the albumin-treated
group revealed a trend towards decreased mortality
in patients with septic shock, and a trend towards
increased mortality in trauma patients, especially
those with traumatic brain injury. This study had
conclusive evidence that 4% albumin is as safe as
saline for resuscitation, although no overall benefit
of albumin use was seen. The commonly used
higher albumin concentrations require rigorous
evaluation in clinical trials.
The Cochrane Injuries Group Albumin Reviewers
continuously publishes an update of the original
eta-analysis. Their last search was updated in
August 2004.7 The conclusion was that there is no
evidence that albumin reduces mortality when
compared with cheaper alternatives such as saline in
critically ill patients with burns and hypoalbuminemia
or hypovolemia (Table 1). Very recently, Vincent et
al8 looked at the effect of albumin administration on
morbidity (including death) in acutely ill
hospitalized patients. In their meta-analysis, they
analyzed a nonselective, transparent large data
sampling of 71 trials. They concluded that albumin
r duces morbidity in a broad category of acutely ill
hospitalized patients. To make a recommendation
from this study, one needs to study the data
carefully, as the median duration of follow-up for all
included trials was only 4 days. Also, the number
needed to treat to avoid one complication was 44
pa ients. Using such costly therapy in this meta-
analysis, there was no evidence that this was
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Use of adrenaline as an adjunct to
local anesthetic agent. A cause of
concern for the anesthesiologist
Mobarak H. Ansari, MD, Annamma Abraham, DA.
drenaline is an endogenous catecholamine. It is
a sympathomimetic agent that has both a and b
adrenergic effects. Physicians mainly use it as a
bronchodilator, during cardiopulmonary resuscitation
and in the treatment of acute anaphylactic reactions.
We often use adrenaline in a concentration of 5
µgm/ml (1:200,000) to reduce blood flow and slow
the rate of absorption of the local anesthetic agent,
thus reducing the plasma concentration and
prolonging the duration of action.1 It has been
recognized for a long time that halothane and, to a
lesser extent, other volatile anesthetics sensitize
myocardium to the arrhythmogenic effects of
adrenaline. Sensitization is the interaction between
volatile anesthetics and catecholamines that leads to
reductions in the threshold for both atrial and
ventricular arrhythmias. Sequentially escalating
doses of adrenaline produce premature ventricular
contractions and sustained ventricular tachyarrhythmias
during halothane anesthesia. Pretreatment with
thiopentone attenuates halothane-adrenaline induced
arrhythmias, presumably via effects on the
atrioventricular node or the upper bundle of  His.
The doses of adrenaline required to produce
ventricular arrhythmias during desflurane or
sevoflurane anesthesia are similar to, but
significantly less than those observed during
administration of isoflurane and halothane.2
However, Katz and Katz3 made 3 suggestions for
translated to a better outcome in terms of shorter
ICU/hospital stay or hospital discharge.
Furthermore, the albumin used by the trials included
varied from 2-25% albumin concentration.
Although they calculated the total amount of
albumin received in grams, the question remains
whether it is the concentration of albumin
preparation used, the target serum albumin level or
the total grams of albumin received, that matters?
Albumin has been used for over 50 years for fluid
resuscitation i the ICU, despite the lack of any
adequately powered randomized clinical trials. As
yet, there is no evidence to support the widespread
use of albumin. There is no convincing data
justifying administration of albumin either for
treating hypovolemia or for correcting
hypoalbuminemia. Until convincing data pro
albumin is presented, injudicious use of albumi  is
not to be recommended. Further trials are required
to form optimal fluid regimens, and indications.
That use of albumin in critically ill patients should
urgently be reviewed by the critical care
practitioner. It should not be used outside the
context of rigorously conducted randomized
controlled trials. 
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Table 1 - Cochrane Database Systematic Review result on albumin
use in critically ill patients from 32 trials (updated August
2004)*: 
Patients category
Hypovolemia
Burns
Hypoalbuminemia
Relative risk of death
1.01
2.4  
1.38
95% Confidence interval
0.92 - 1.1 
1.11 - 5.19
0.94 - 2.03
*The pooled relative risk of death with albumin administration 
was 1.04.
A
Albumin
adrenaline. However, clinical acumen and awareness
of the committed anesthesiologists will be the key in
prevention and finding an apt solution to this
seemingly insignificant yet, potentially hazardous
problem.
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clinical precautions that have stood the test of time.
1. We should only use solutions of adrenaline of
1:100,000-1:200,000. 2. The dose in adults should
not exceed 10 ml of 1:100,000 adrenaline in any
10-minute period. 3. The dose in adults should not
exceed 30 ml of 1:100,000 adrenaline in any given
60-minute period. The Ear Nose and Throat, Plastic,
Dental and Neurosurgeons mainly use adrenaline
mixed with lidocaine. Different studies have
revealed that ranges of hemodynamic changes occur
by the addition of adrenaline to either lidocaine or
normal saline (Table 1).4-6 
In a study conducted by Murthy and Rao5 among
5 groups, 4 groups of patients developed significant
hemodynamic changes irrespective of mixtures and
the concentrations of adrenaline used. Likewise, in
another study conducted by Phillips et al,6 among
the 4 groups, 2 of the study groups of patients
developed significant hypotension, unlike the
control groups when they mixed adrenaline with
lidocaine and normal saline. Moreover, in tumescent
anesthesia where the volume of the local anesthetic
mixed with adrenaline is relatively more, it poses a
greater threat to the development of potentially fatal
cardiovascular responses, as the likelihood of
exceeding the maximum dose of adrenaline
increases further.
These hemodynamic hanges are typically
transient, and pretreatment with metoprolol (1 mg,
IV) has been effectively used to alleviate the
adverse cardiovascular responses to adrenaline
infiltration.7 Nonetheless, they may often be life
threatening.4-6 Currently in the literature, there is a
lack of reliable information on measures to prevent
or effectively counteract these adverse ffects of
Table 1 - Studies showing potentially serious hemodynamic side effects of ADR when used as an adjuvant to LDC among patients undergoing
various surgical procedures. 
Pasternak et al4
Murthy and Rao5
Phillips et al6
2004
2001
1993
      LDC + ADR
5 Groups
LDC
 LDC + ADR
 LDC + ADR
N. saline + ADR     
N. saline + ADR     
4 Groups
LDC
 LDC + ADR
N.Saline
N. Saline + ADR     
--
LDC-0.5% (Control)
LDC-0.5%, ADR 1:200,000
LDC-0.5%, ADR 1:100,000
NaCl-0.9%, ADR 1:200,000
NaCl-0.9%, ADR 1:100,000
LDC-0.5% (Control)
LDC-0.5%, ADR 1:200,000
NaCl-0.9% (Control)
NaCl-0.9%, ADR 1:200,000
100
112
  20
  23
  24
  23
  22
  80
-
-
-
-
Arterial hypertension (58%)
No significant hemodynamic changes
Biphasic hypotension
Biphasic hypotension
Diastolic hypertension
Severe tachycardia
No significant hemodynamic changes
Hypotension (55%)
No significant hemodynamic changes
Hypotension (40%)
Author and referenceYear Drug combination Composition No. of patients Side effects (%)
LDC - Lidocain, ADR - adrenaline, N. saline - normal saline, NaCl - sodium chloride
Adrenaline with local anesthetic
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course was uneventful, she was discharged home on
the 4th day of admission. 
Hemorrhage from ruptured ovarian vessels is a
rare but life-threatening complication during
pregnancy.1 Mojab and Rodriguez,2 and Ginsburg et
al3 discussed postpartum ovarian artery rupture with
retroperitoneal hemorrhage and post-partum
spontaneous rupture of a branch of the ovarian
artery. The clinical manifestation is mostly
abdominal pain with hemodynamic ollapse.
Laboratory findings show a decrease of hemoglobin
and hematocrit levels. Ultrasound examination
demonstrates free fluid in the abdomen. At the
beginning after delivery she had no signs of
hemodynamic instability. The blood loss developed
slowly and the level of hemoglobin decreased
gradually; the young patient could adjust to the
decreasing circulating volume of blood. Finally, she
began to show signs of hemodynamic instability.
The treatment consists of preoperative hemodynamic
stabilization of the patient and urgent laparo omy.
Rupture of uterus, uterine artery, utero-ovarian
vessels, adrenal-gland vein, splenic vein, renal
arterial aneurysm, kidney, liver or spleen should
remain in differential diagnosis.3 Cardiac output,
heart rate, blood volume increases, and hormonal
factors may impair the arterial wall and additional
stress such as delivery may result in the spontaneous
rupture of ovarian artery.4 Structural changes in
intima and media of the arterial wall are
demonstrated uring pregnancy. The observed
hyperplastic intimal changes are histologically
equivalent with the changes that appear with
hypertension and oral contraceptive use.5 All th se
changes during pregnancy may contribute to the
etiology of  spontaneous ovarian artery rupture
following spontaneous vaginal birth. It is still
controversial whether the arterial wall weakens
during pregnancy and additional stress such as
delivery or previous cesarean section may cause
spontaneous rupture of ovarian artery.  
Spontaneous rupture of an ovarian artery after
delivery is an extremely rare complication. One
must think about it in cases of diffuse abdominal
pain and hemodynamic collapse. The treatment
consists of performing a laparotomy with suturing
of the ruptured ovarian artery.
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Spontaneous rupture of the ovarian
artery following spontaneous vaginal
birth
Ahmet Kale, MD, Nurten Akdeniz, MD, 
Mahmut Erdemoglu, MD, Yilmaz Ozcan, MD,
Ahmet Yalinkaya, MD. 
emorrhage from ruptured ovarian vessels is an
extremely rare but life-threatening complication
during pregnancy.1 These are very few earlier
reported cases on postpartum ovarian artery rupture
after delivery.2-3 We describe a patient with
spontaneous ovarian artery rupture 5 hours after
delivery.
A 30-year-old woman, gravida 5 para 5 (G5P5)
was referred to the Obstetrics Department with the
complaint of diffuse abdominal pain and minimally
vaginal bleeding 5 hours after delivery. The pain
was associated with nausea and vomiting. Her
antenatal course was uneventful, and past obstetric
history included a previous cesarean section
followed by 3 normal vaginal births no systemic
illness. On physical examination, she seemed to be
in moderate distress secondary to abdominal p .
The body temperature was 37°C, heart rate was 110
beats/min, respiratory rate was 20 breaths/min, and
blood pressure was 90/60 mm Hg. Abdominal
examination revealed diffuse and rebound tenderness.
Pelvic examination revealed a tender uterus with a
post delivery open cervix and minimal vaginal
bleeding. The attending radiologist performed
ultrasonographic examination, which revealed a
normal liver and spleen. Perihepatic and perisplenic,
an amount of free fluid was visible in the abdomen.
Her hematologic workup demonstrated hemoglobin
=8.38 g/dl (normal range [NR]: 12.3-15.3 g/dl),
hematocrit=4.1% (NR: 37.7-53.7%), white blood
cell=1300 (NR: 4.4-11.3 uL), platelet counts=385,000
x 103/ul (NR: 142-424 uL). Hemoglobin level
gradually decreased and she seemed to enter a state
of shock. We performed emergency exploitive
laparotomy with a suspicion of uterine rupture.
After opening the peritoneum approximately 1500
ml blood was aspirated. There was no retroplacental
hematoma. Further inspection of uterus, tubes, and
ovaries were normal. The liver, spleen, stomach,
gallbladder, and intestines howed no signs of
bleeding. Closer inspection showed the spontan ous
rupture of left ovarian artery, which was bleeding.
Left ovarian artery was sutured primarily and we
observed no further bleeding. After operation she
was referred to their intensive care unit in a stable
condition. She was transfused with 5 units of blood
intra- and postoperatively, and as the postoperative
H
Spontaneous ovarian rupture 
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humerus, both nerve and artery pass through the
antecubital fossa underneath a fibrous sheath and
the bicipital aponeurosis, which takes origin from
the biceps tendon and the fascia of the flexor-
pronator mass. It then passes between the 2 heads of
the pronator teres. In this muscle, the largest branch
can be found, the anterior interosseus nerve. The
nerve continues in the forearm between the flexor
digitorum profundus and flexor digitorum
superficialis.2
 We encountered 2 anatomic variations that can
cause entrapment neuropathy of the median nerve
during our routine student dissections. In one of our
dissections, we encountered a variation of the
median nerve at the level of the Br. The cadaver was
a 47-year-old male and has no visible scars or
wounds on both upper extremities. Normally, the
median nerve courses in the groove between the
biceps brachii (BB) and Br.2 The median nerve can
be compressed above the elbow due to an accessory
tendon, which arises form the Br in 10% of the
cases. According to some authors, the muscle fibers
arise form the Br connect to some of the fibers of
BB and end in bicipital aponeurosis and compress.
In this case, which is located in the arm, at 9 cm
proximal to the medial epicondyle, the nerve leaves
the brachial artery and passed through the
antecubital fossa piercing the Br (Figure 1a). The
course of the median nerve on the other arm was
normal. In another dissection, we encountered an
abnormal pattern of the accessory head of flexor
pollicis longus (FPL) (Gantzer’s muscle). The
cadaver was a male with unknown age with no
visible scars or wounds on both upper extremities.
 Gantzer’s muscle is the accessory head of the
FPL, which usually originates from medial
epicondyle or processus coronoideus and lies on the
ulnar side of the FPL. It has been implicated as one
of the causes of the anterior interosseous nerve
(AIN) compression in the proximal forearm.1,3-5 The
anterior interosseous nerve is the largest branch of
the median nerve is the forearm and has no sensory
fibers.2 The incidence of the Gantzer’s muscle was
reported between 45-74%.3-5 The difference of these
ratios might be due to the fact that the muscle can be
fused with some of the superficial flexor group and
can be overlooked uring dissection. The muscle
usually passes between the superficial branch of the
median nerve and the anterior interosseous nerve;
but rarely passes superficially to both of the nerves.2
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Two anatomic variations in the arm
related to the median nerve
Burak Bilecenoglu, MD, Aysun Uz, MD
Nazim Karalezli, MD, Sinan Issi, MD.
isorders of the peripheral nervous ystem are
quite common; of these disorders entrapment
neuropathies are frequently encountered by the
clinician. The term entrapment neuropathy implies
that the nerve is compressed by adjacent anatomic
structures.1-2   Distribution of the median nerve in the
arm is rarely subjected to variation, but there are
numerous report regarding median nerve
compression. Variations of the nerve and the
adjacent structures may be seen clinically or
observed during surgery, autopsy or cadaveric
dissection. We recently encountered 2 anatomic
variations that can possibly cause entrapment
neuropathy of the median nerve during our routine
cadaver dissections. Typically, the median nerve
receives fibers from C6, C7, C8 and T1 spinal
nerves and supplies motor, sensory and sympathetic
nerve fibers to the upper limb. In the arm, its course
is closely related to the brachial artery. Along with
the brachial artery, it travels between the brachialis
(Br) and the medial intermuscular septum in the arm
until it reaches the nerve and the cubital fossa,
which has no branches.  Sometimes a small branch
to the brachial artery can be seen. At the distal
D
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mind by orthopaedic surgeons dealing with the
surgical interventions and release operations related
to the entrapment neuropathies of the upper
extremity.
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The most frequent site of origin of the muscle has
been reported to be the medial epicondyle of
humerus, a well-developed connecting fascia made
up of the intermuscular septa among the pronator
teres and flexor muscles in the proximal forearm,
flexor digitorum superficialis and both the medial
epicondyle and coronoid process.3-5 However, the
most frequent site of the origin of the muscle has
also been reported to be the coronoid process in
87.5%. In the forearm the muscle ends in the ulnar
part of the FPL or ends in 2 tendinous slips, one of
which connects to FPL, whereas the other coursed
to join the tendon of the flexor digitorum profundus
(FDP) to the index finger.3-5 Although the accessory
head of the FPL is not a rare variation,3-5 in our
dissection the accessory head was seen as 2
tendinous lips clearly different that have been
reported and course of these slips were extremely
different from the cases in the literature. It turns to
the radial side and fuses to the FPL immediately
after its origin, and it seemed to compress the
anterior interosseous nerve strongly especially when
the forearm is in supination (F gure 1b). When the
forearm is in pronation there is no significant effect
on the nerve (Figure 1c).
 In this study, we report 2 anatomic variations
that are responsible for entrapment neuropathies of
the median nerve. These variations must be kept in
Figure 1 - Photograph showing: (a) Right arm, elbow. BB - biceps
brachii, Br - brachialis, M - median nerve. The figure
shows the median nerve piercing the brachialis muscle.
(b) Left arm, distal of the elbow joint deep compartment,
supination. FD -flexor digitorum profundus, FLP - flexor
pollicis longus, AIN - anterior interosseal nerve, Black
arrowhead: Gantzer’s muscle seen as 2 tendinous slips.
The figure shows the accessory head of the flexor
pollicis longus in supination. (c) Left arm, distal of the
elbow joint deep compartment, pronation. FDP - flexor
digitorum profundus, FLP - flexor pollicis longus, AIN -
anterior interosseal nerve, Black arrowhead: Gantzer’s
muscle seen as 2 tendinous slips. The figure shows the
accessory head of the flexor pollicis longus in pronation.
a c
b
Variations of the median nerve
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visualized by exposure to ultraviolet light after
ethidium bromide staining. A female staff member
performed all procedures including blood specimen
collection and preparation, DNA extraction and PCR
amplification. To determine the specificity of male
genomic DNA in a single PCR using SRY forward /
SRY 3’-nested primers; we examined 15 male
genomic DNA and 15 female genomic DNA
samples. All the male samples were positive and
produced a 173 bp fragment while the 173 bp
fragment was not detectable in the female samples
(Figure 1). We amplified all female samples giving
negative results for the Factor VIII gene, as a
positive control (data not shown). To evaluate the
sensitivity of the developed assay, we applied the
single PCR, using SRY forward/SRY 3’-nested
primers, to serial dilutions of 220 ng of male
genomic DNA in female genomic DNA. Positive
signals were detected up to the 1/10000 dilution,
which is almost at the 3 cells level (data not shown).
We developed a new single PCR of a nested PCR
for sex determination, which is able to identify Y-
specific signals with no false-positives and false-
negatives. Honda et al5 developed a single PCR by
use of the internal pair of primers used in the nested
PCR devised by Lo et al.3 This study is an attempt
to cross-use one primer from the external pair of
primers and another from the internal pair of
primers of a nested PCR to develop a single PCR.
Although this method is incomparable to real time
quantitative PCR, it has overcome the difficulties of
nested PCR and provided a feasible methodology
with an acceptable specificity and sensitivity.
However, the sensitive nature of this assay, which
can detect copies at the 3 cells level, implies that
great care must be taken to avoid contamination.
Sex determination using sex
determining region Y primers by
single conventional polymerase chain
reaction
Nafisseh Pakravan, Ms, PhD, 
Fereydoun A. Ala, MD, FRCPath
Ghassem Rastegar Lari, Ms, PhD. 
he development of the polymerase chain
reaction (PCR) as a means of amplifying known
sequences of DNA allows determination of gender
by amplification of sequences unique to the Y
chromosome. Detection of Y-specific sequences has
clinical importance as it would be useful in fetal
gender identification in mothers who are carriers for
X-linked disorders and in forensic medicine.1 There
were reports dealing with sex determination to
detect Y-specific sequences by PCR. Established
PCR-based on sex determination methods using the
X–Y homologous region of the amelogenin gene,2
the Y chromosome specific sequences include the
Y-specific repeat sequences, DYS14,3 and the sex
determining region Y (SRY).4  One study used a
nested PCR using SRY forward/reverse as external
primers and SRY-5’netsed/3’-nested as internal
primers5 for detection of Y-specific sequences. The
difficulties with the nested PCR prompted us to
develop a single conventional PCR by cross-using
the SRY forward/SRY 3’-nested primers.
We prepared genomic DNA from the peripheral
blood samples collected from adult males and
females in EDTA-containing tubes. Cell-free DNA
from plasma to plasma by using QIAamp DNA
blood Mini Kits (Qiagen, UK) according to the
blood and body fluid protocol with minor
modifications. Primers for amplification of 173 bp
sequence are as follows: 
 SRY forward: 5’GTG TCC TCT CGT TTT GTG
AC 3, 
SRY 3’-nested: 5’CTA GTA CCC TGA CAA TGT
ATT C 3’. 
We performed PCR amplification in a total volume
of 25 µl containing extracted DNA, 200 µM dNTPs,
20 pmol of each primer, 1 x Taq polymerase buffer
(containing 1.5 mM MgCl2), and 1 U of Taq
polymerase (Roche Biochemicals). The thermal
cycling began with denaturation at 94°C for 7
minutes, followed by 40 cycles of  94°C for 30
seconds, 55°C for 30 seconds, and 72°C for one
minute, with final incubation at 72°C for 12
minutes. The PCR amplification products were
separated by 8% acrylamide gel electrophoresis and
T
Figure 1 - Photograph of electrophoresed polymerase chain reaction
products of 4 males and 3 females genomic DNA. Lane 1
represent molecular weight marker VIII (pUCBM21 DNA
cleaved by Hpa II, Dra I and Hind III). Lane 2, 3, 4 and 5
represent male DNA. Lane 6, 7 and 8 represent female
DNA.
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magnesium between cases who died from
cardiovascular diseases and controls.2
Jorde et al3 shows that total serum calcium is a
predictor of cardiovascular disease in men. We
performed this cross-sectional study in order to
compare the status of total serum calcium and
phosphorus levels in patients with coronary artery
disease (CAD) with normal controls. We used a
questionnaire for demographic data and we
excluded patients with malignancy, renal failure
(creatinine >1.5 mg/dl), liver diseases, digestive
disorders, hyperthyroidism, and those undergoing
treatment with thiazide diuretics. We collected
blood samples for measurement of serum total
calcium, phosphorus, urea, creatinine, triglyceride,
uric acid, cholesterol and fasting blood sugar after
overnight fasting, and we determined biochemical
parameters with ordinary kits using RA 1000
apparatus.
The patients underwent routine coronary angiography
using optimus-M 200 Philips angiography system.
The number of the vessels with significant stenosis
(>50%) was detected by a cardiologist who was not
aware of the investigation. Stenosis less than 50%
was known as non-significant lesions and were
excluded. We analyzed all data through EPI info
2000 and p values <0.05 were considered as
statistically significant, after gathering the samples
and data recording in the questionnaire. We studied
a total of 230 consecutive patients (149 males and
81 females) admitted for coronary angiography in
Shafa Hospital. Their age ranged from 23-78 years
with a mean age of 52.8 + 11.2 years, 142 (61.7%)
patients had CAD (group I) and 88 (38.3%) subjects
had normal coronary angiogram, as control group
(group II). Single vessel disease was detected in 58
(40.8%), 2 vessel disease 33 (23.3%), and 3 vessel
disease 51 (35.9%) of patients with CAD. Mean age
was (55.1 + 10.2 years in group I, 47.9 + 11.6 years
in group II). The mean age was significantly higher
in group I (p<0.0001). Patients with CAD had
diabetes mellitus, high blood pressure, hyperlipidemia,
and smoking habitus more than control group, ( all
p-values <0.05). The mean calcium and phosphorus
concentrations in the 2 groups are given in Table 1.
The concentration of calcium and phosphorus did
not significantly differ between patients with CAD
and normal controls. Serum calcium and phosphorus
levels had no significant association with the
number of vessels diseased. We indicated calcium
has an important role in the pathogenesis of
atherosclerosis, an association between serum
calcium and the metabolic syndrome.4 If such an
association exists, one would expect serum calcium
to be related to CAD. We suggested high serum
total calcium concentration to be an independent
risk factor for myocardial infarction in middle aged
men.5 In our study, the mean levels of total serum
calcium and phosphorus were not significantly
different between the patients with and without
Due to the sensitivity of this method it could
potentially be used for prenatal sex identification
using free fetal DNA in maternal plasma or serum in
addition to chorionic villous samples. Therefore,
considering the sensitivity of the assay, it could be
used in parallel with other Y-specific assays to
increase the certainty of the results. 
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Serum calcium and phosphorus levels
in patients with ischemic heart
disease
Mohammad Masoomi, MD, Afsaneh Foroud, MD,
Masoomeh Karami, MD.
schemic heart disease (IHD) is estimated to be the
leading cause of lost life years until at least 2020.1
There is a long list of well known risk factors for
cardiovascular diseases but limited work has been
carried out on the relation of serum calcium and
phosphorus levels with IHD, and their results are
controversial. Calcium is a vital electrolyte, in
normal adults plasma level ranges from 2.2-2.6
mmol/l (8.8-10.4 mg/dl). Plasma concentration of
phosphorus is normally 2.5-4 mg/dl. In a case
control study of men in Finland with 10 years
follow up, there were no significant differences in
concentrations of serum calcium, and serum
I
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provides information not only regarding changes in
glycolysis, but also on anaerobic work capacity.
Blood sampling involves blood loss, emotional
stress and discomfort, whereas aliva is easy to
collect and non-invasive. Several authors have
described the possibility of evaluating the changes
produced in the composition of saliva in response to
exercise as a non-invasive method of determining
lactate threshold.1,2 There is some research, which
shows parallelism between the saliva and blood
lactate response during incremental exercise.2 The
aim of this study is to investigate whether there is a
relation between lactate increase of blood and
saliva, during seated recovery after supramaximal
exercise.  
A group of 10 male athletes, practicing an
average of 6 hours of sports activities per week, and
with an acceptable level of physical fitness, agreed
to participate in the study after the objectives of the
investigation and the protocol to be followed was
explained to them. The characteristics of the
participants were as follows: average age 21.4 ±
1.50 years (range 21-26.5 years), height 179 ± 4.01
cm (range 174-189 cm), weight 81.7 ± 13.30 kg
(range 65 - 100 kg), and body mass index 25.4 ±
4.40 kg/m2 (19.4-30.3 kg/m2). No athlete has a
smoking habit. All participants followed their
customary diets and performed their habitual
professional and recreational activities. The time of
experiment (10:00-12:00 am) was chosen to
minimize the influence of circadian variations in
salivary flow and composition. The test was
performed at a minimum of 3 hours after breakfast
and conducted in a well-ventilated room with an
ambient temperature of 20-24OC, and relative
humidity ranging between 40-55%. The subjects
performed a Wingate anaerobic power test (WAPT)
on Monark 814 E (Monark Exercise AB, Vansbro,
Sweden). They warmed-up for 5 minutes at a
pedaling rate of 60-70 RPM against a resistance
equal to 20% of that was calculated for the
subsequent WAPT. Two unloaded 5-second sprints
were performed at the end of the 3rd and 5th minute
of the warm-up period. The maximal pedaling rate
(RPMmax) attained during the sprints was recorded.
Following a 5 minute rest to eliminate any fatigue
associated with the warm-up, they performed the
WAPT against a resistance of 0.75 kg/kg body
mass. They were instructed to pedal as fast as
possible from the onset of the test. The resistance
was applied when 70% of the previously recorded
RPMmax was attained. They were verbally
encouraged to maintain as high a pedaling rate as
possible throughout the 30 second test duration.
Heart rate was monitored throughout the warm-up,
the test and the recovery method using a sport-
CAD, and serum calcium and phosphorus had no
significant association with the angiographic
severity of CAD. 
Narang et al,6 showed that serum phosphorus had
an independent positive association with the
angiographic severity of CAD. In this study, we
could not measure the amount of calcium de osition
in atherosclerotic plaques of patients with CAD, but
regarding the unique concentrations of the total
serum calcium and phosphorus between 2 groups of
patients with and without CAD, our data suggests
that the total serum calcium and phosphorus had no
relation with IHD.
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Blood and saliva lactate levels during
recovery from supramaximal exercise
Hilmi Karatosun, MD, PhD, Cem Cetin, MD, PhD,
Metin L. Baydar, MD, PhD.     
actate is now recognized to be an important
source of energy for skeletal muscle metabolism,
measuring blood lactate concentration (samples)
L
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taken during rest and recovery (Friedman p<0.001).
Blood lactate increased 10 mmol (600%), 11 mmol
(650%), and 7.75  mmol (455%) at R0, R5 and R15,
from resting value and decreased 3.25 mmol (26%)
at R15, according to R5 value (Wilcoxon, p<0.012).
Saliva lactate indicated an increase at R0 of 0.03
mmol (14%), R5 at 0.06 mmol (29%) and R15 at
0.22 (104%) mmol compared with resting level
(p<0.012). Plasma and saliva lactate values are
presented in Table 1. 
According to Wilcoxon test, the differences
between time points of measurement are significant
p<0.01. There is no correlation between sample time
values of blood and salivary lactate. The percentile
of lactate increases with the sample time as
presented in Table 2.
The study suggests that blood lactate peak occurs
at the 5th minute of recovery, and saliva lactate
peak occurs at 10-15th minutes of recovery.1,3
Segura et al2 and Chicharro et al,4 found a good
correlation between the concentrations of salivary
and blood lactate, and they proposed the
determination of lactate in saliva may be an
alternative to the determination i blood at a
maximum graded test on a cycle ergometer.
Ohkuwa et al1 cannot explain on physiological
grounds why salivary lactate would significantly
increase following a 400 m and 3000 m run, when
compared with the basal level or whether salivary
lactate concentration during recovery was
significantly lower compared to blood lactate
concentration, or whether the peak concentration of
salivary lactate occurs later than the peak of blood
lactate. One possible reason may be that salivary
lactate is diffused passively through the salivary
glands from the blood. At present, the origin of
salivary lactate after exercise is not yet clear.1 
In this study, during the post-exercise inactive
recovery, plasma lactate showed an increase of
600% at R0, 650% at R5 and saliva lactate indicated
Tester heart-rate monitor (Polar Electro, Kemp le,
Finland). The blood samples from all subjects were
taken in tubes with sodium fluoride (NaF) from the
antecubital region for lactate analysis, before the
warm-up (rest), immediately after exercise (R0), 5
(R5), and 15 (R15) minutes following the WAPT in
the inactive seated recovery period. Saliva sa p es
were obtained at the same time with blood samples.
Each subject was instructed to floss his teeth and
thoroughly clean the oral cavity the night before
saliva collection. Thirty minutes before the exer ise
test, each subject was given 500 ml of water to
ensure adequate body hydration. The mouth was
rinsed with deionized water immediately before
saliva collection (resting or after exercise). In
addition, each subject was instructed to empty his
mouth of "old" saliva before spitting into a sterile
container. Samples were kept at 4OC and transported
to the laboratory. Once in the laboratory, samples
were centrifuged and supernatants were separated
and stored at –80OC. In order to reduce the
variability to a minimum level and to avoid any
possible interference, the clear transparent upper
layer of the saliva samples was used for the actate
determination. Blood and saliva samples were
analyzed using lactate PAP kit (Milchsaeure,
Boehringer, Ingelheim, Germany) with a UV-
Spectrophotometer (Philips Electronics, Eindhov n,
The Netherlands) at the wavelength of 505 nm.
Following performance of the homogeneity test; it
was observed that the variances were not
homogenous (p>0.05). While the Friedman Test
was applied to compare the difference between
Rest, R0, R5 and R15 measurements, Wilcoxon test
was applied to determine from which groups the
difference emerged. Significance level was accepted
as p<0.012 by performing Bonferroni correction ( /
k, k= comparison coefficient).
The differences were found significant between
blood and saliva lactate values, at the measuremen s
Table 1 - The values of plasma and salivary lactate (mmol/l). 
Blood lactate
Median
Min-max
Saliva lactate
Median
Min-max
1.7
(1.22-2.53)
  0.21
  (0.9-0.30)
11.7
  (1.22-2.53)
    0.24
  (0.11-0.49)
12.7
     (8-16.20)
    0.27
    (0.9-0.56)
9.45
(5.20-13)     
0.43
(0.22-0.63)  
0
0
Rest R0 R5 R15 p
Blood lactate
Rest
Saliva lactate
Rest
(600)
  (14)
(650)
  (29)
(455)
(104)
R0
(%)
R5
(%)
R15
(%)
Table 2 - Percentile of lactate increases compared with resting level. 
Rest  - before warm up, R0 - immediately after exercise, R5 - 5
minutes during recovery, R15 - 15 minutes during recovery.
Variables Variables
Rest  - before warm up, R0 - immediately after exercise, R5 - 5
minutes during recovery, R15 - 15 minutes during recovery.
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Target level controlled sedation. An
alternative to general anesthesia in
endovascular treatment of intracranial
aneurysms 
      Ahmet C. Senel, MD, Ahmet Akyol, MD, 
Halil Uzunlar, MD, Ahmet Eroglu, MD.
ontrolled sedation, commonly used to describe
the process of administering sedatives or
dissociative agents with or without analgesics to
induce a state that allows the patient o tolerate
unpleasant procedures by relieving anxiety,
discomfort, or pain; while maintaining independent
cardio-respiratory function is a term we refer to as
target level controlled sedation (TLCS).1
Endovascular therapy as interventional neuro-
radiology (INR) is now an established therapeutic
alternative to surgical clipping of some cerebral
aneurysms.2   In most institutions, an anesthesiologist
is involved in the care of the patient during INR
treatment.3 The roles of the anesthesiologist in the
INR suite are to  monitor the patient, to provide
appropriate anesthesia to facilitate the procedure,
and to manage any complication that may arise.
Embolization is usually performed under general
anesthesia (GA) but in our study, we evaluate TLCS
using 2 different agents in the anesthetic
management of patients during the treatment of their
cerebral aneurysm in the neuroradiology suite. 
After approval of the Institutional Ethics
Committee, and obtaining informed consent; 63
American Society of Anesthesiologists (ASA) I-III
patients (37-68 years old, at least one week later
than their subarachnoid hemorrhage) undergoing
treatment for intracranial aneurysms  by Guglielmi
detachable coils (GDC) embolization were enrolled
for our study. Patient demographic data, and current
events prior to treatment, including the neurological
status of the patient and duration of the procedure
were documented. We established the intravenous
access in the left hand. Patients were premedicated
with midazolam 0.05 mg/kg and fentanyl one mg/kg
intravenously (IV), and oxygen supplementation
was stated at 2 L/min via nasal cannulae. After
randomization, patients received an initial dose of
propofol (10 mg/ml Fresenius-Kabi GmbH, Austria)
0.5 mg/kg (group P) or midazolam (one mg/ml,
Dormicum, Roche, Basel, Switzerland)  0.05 mg/kg
(group M), followed by an infusion of either
propofol or midazolam as a sedative agent. The
infusion rate was adjusted to maintain a sedation
level of "5" by Ramsey Sedation Scale. If there was
movement during the procedure, patients received
an increase of 14% at R0 and 29% at R5, pl sma
lactate was eliminated by 26% at R15, while saliva
lactate increased by 104% at R15, compared to the
resting values (Table 2). As can be seen, plasma and
saliva lactate show different types of dynamics and
there is not a linear relation between the 2. When
the percentage increase of saliva lactate is compared
with that of plasma lactate in our previous study as
well as in present study, no relation between them is
observed. However, following WAPT, saliva lactate
levels at the post-exercise 15th minute in the
previous and current studies were the same (0.43
mmol/l). Our results do not indicate the presence of
any significant relationship between saliva and
blood lactate values.5
It is expected that salivary lactate levels are parallel
with plasma lactate levels with increasing
workloads. Some studies suggest that determination
of lactate in saliva may be an alternative to blood
lactate investigation.2 In both studies our plasma
lactate and saliva lactate showed increases with
supramaximal loading. There was no significant
correlation between the peak lactate of saliva and
blood increase, also percentile of lactate increases in
blood and saliva, after supramaximal exercise. 
In conclusion, it seems doubtful to estimate
plasma lactate level by using saliva lactate level
after supramaximal exercise.  
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sedation that was adequate for the completion of the
procedure. 
Traditionally, the treatment of cerebral aneurysms
involved surgical intervention,4,5 but recent
developments in INR have resulted in more patients
undergoing endovascular coiling. There is little
information in the literature regarding the anesthetic
management of patients with cerebral aneurysms
undergoing endovascular treatment. Our goal was to
manage GDC embolization of the patients in the
INR suite with TLCS. Target level controlled
sedation; the less invasive approach of INR may be
a good alternative in the management of
embolization procedure. In addition, to reducing the
risk associated with GA, performing GDC
embolization under sedation permits regular
neurological evaluation of the patient throughout the
procedure. In the event of a thromboembolic
complication, early detection of neurological
deficits and their severity allows timely and
appropriate use of thrombolytic therapies. The
technique of anesthesia used for INR procedures
varies from light sedation to GA from hospital to the
hospital, but often GA is the preference of the
neuroradiologist.6 Another benefit of TLCS in GDC
embolization of the aneurysms is; during TLCS, the
patient serves as an effective overall monitor of
neurological status. In INR, the ability to assess the
neurological status of patients during the procedure
or immediately at the end of the procedure is
desirable. The maintenance of optimal level of
blood pressure is also very important during these
procedures. The sedative agents in TLCS also help
to maintain intended mean arterial pressure during
the procedure. The level of mean arterial blood
pressure during the procedure in this study was
similar in both propofol and midazolam groups, and
we did not have any problem with the maintenance
additional bolus doses of propofol 0.3 mg/kg in
group P, and midazolam 0.03 mg/kg in group M.
After the femoral artery puncture and the initial
angiogram, a 6F (2-mm diameter) nontapered guide
catheter is placed in the internal carotid or vertebral
artery. This guide catheter allows the passage of the
microcatheter for contrast injection to perform
angiograms and road mapping. Road mapping is a
computer substraction technique that allows the
interventional neuroradiologist to see in real time
the radio-opaque ndovascular tools in super-
imposition with a map of the intracranial rteries.
Anticoagulation is provided with 3000-5000 IU
heparin IV, followed by 1000 IU per hour.
Heparinization is necessary due to the risk of
thromboembolic complications.  In the embolization
procedure, coils of decreasing sizes were delivered
into the aneurysm cavity and electrolytically
detached. We recorded all complications
(desaturation, apnea, hypotension, hypertension,
bradycardia, tachycardia) elevant o sedation and
the procedures. At the end of the procedure, the
radiologist was asked to evaluate patient sedation in
terms of excellent (no movement), good (one
movement, no critical time), average (more than one
movement or one movement at critical time) or poor
(failed sedation; unable to perform procedure). Data
for groups are presented as mean ± SD. Statistical
analysis was performed with Chi-square and t-tests
where appropriate, a p-v lue <0.05 was considered
significant. 
Sixty-three ruptured aneurysm patients und rwent
GDC embolization under TLCS. There were 38 men
and 25 women with a median age of 51 years (range
37-68 years). The 2 patient groups were similar with
respect to age, gender, duration of the procedure and
Glasgow Coma Scale (GCS) (Table 1). The mean
GCS of the patients before the procedure was 11.4 ±
3.3 in group M, and 11.9 ± 2.7 in group P. The
duration of the procedure ranged from 89 to 213
minutes without significant differences between the
2 groups (Table 1). Coiling procedure was achiev d
successfully in all patients. The mean infusion rate
to maintain "Ramsay Sedation Score 5" all t rough
the procedure was 0.03 ± 0.02 mg/kg/h for
midazolam (group M), and 2.9 ± 1.4 mg/kg/h for
propofol (group P) Table 1. Two patients in grou
M and one in group P had decreases in oxygen
saturation to less than 90% with the lowest level
being 84% for more than one minute, but no advers
clinical outcome was detected as a result. Oxygen
saturations normalized after increasing nasal oxygen
supplementation from 2-4 L/min. Except from these
3 patients, no serious respiratory or hemodynam c
complications occurred with either drug regimens.
There were no other adverse events, or
complications related to sedation in either groups.
All patients satisfactorily maintained a level of
GDC - Guglielmi detachable coils, GCS - Glasgow coma scale.
Table 1 - Profile of patients undergoing GDC treatment of cerebral
aneurysms.
No. of  patients
Duration of procedure (min)
Age (year)
Weight (kg)
Male  
Female
GCS
Infusion rate (mg/kg/h)
31
131 + 41  
49 + 11
75 + 19
13
18
11.4 + 3.3  
0.03 + 0.02
32
157 + 56  
52 + 15
79 + 21
12
20
    11.9 +2.7     
   2.9 + 1.4  
Group M Group PCharacteristics
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The frequency of skin diseases in
obese children and adult Iraqi
population
Khalifa E. Sharquie, MBChB, PhD, 
Jamal R. Al-Rawi, MSc, FICMS, 
Firas F. Al-Tamimi, MBChB.
besity is a major health problem that is
commonly associated with skin manifestations,
such as acanthosis nigricans and skin tags, but
unfortunately, only limited studies exist concerning
this problem.1 The aim of the present work is to
evaluate the frequency of skin diseases among obese
children and adults. 
This study consists of 2 parts.Part 1: We took a
cross-sectional sample from Basrah primary schools
(urban only). We carried out the study from
December 2003 to March 2004, and included 13
primary schools; 8 for boys and 5 for girls. The
number of pupils in the sample was 4189; 2616
boys and 1573 girls. We used body mass index [
(BMI) = (weight [kg])/height [m]2] to select the
number of overweight and obese subjects
considered for study. There were 52 obese; 34 boys
and 18 girls, and 94 overweight; 56 boys and 38
girls, their ages ranged from 7-13 years. We
considered 100 pupils; 60 boys and 40 girls of
normal weight as the control group, comparable for
age, sex and selected from the same class as the
obese pupils. We carried out a full clinical and
dermatological examination to establish the
of blood pressure or fluid management of the
patients in INR, and no patients required any
pharmacological gents to control their blood
pressure during the procedure. Target level
controlled sedation is an alternative to GA in GDC
embolization of intracranial aneurysms. Monitoring
standards (electrocardiogram, pulse oximetry, non
invasive blood pressure, capnography, central
venous lines for volume status) for anesthesia in the
INR suite, is not different from the operation
room.7,8
Published data suggest that oximetry effectively
detects oxygen desaturation and hypoxemia in
patients who are administered sedatives/analgesics,
and early detection of hypoxemia through the use of
oximetry during sedation decreases the likelihood of
adverse outcomes.9 The use of propofol or
midazolam in INR suite requires the presence of an
anesthetist, as the primary complication of sedation
is related to respiratory or cardiovascular
depression. Safety aspects uch as the need for
assisted ventilation in cases of apnea must be
ready.10 Our results suggest that the application of
sedatives in  TLCS may yield even better levels of
safety compared with the conventional infusion of
midazolam and propofol. The weakness of this
study or the question of the readers may be "why the
authors have not compared TLCS with GA for GDC
embolization procedure?" The brief answer is; there
is no information in the literature regarding the
sedative management of patients with cerebral
aneurysms undergoing endovascular t eatment in
the INR suite. And the next step of this study will be
the comparison of GA versus TLCS.
In conclusion, the anesthetic management of
patients with cerebral aneurysms performed using
GDC embolization under TLCS appears to be
feasible, and allows intra-procedural evaluation of
the patient. Potential advantages of TLCS include
early detection of neurological complications,
decreased cardiopulmonary morbidity rates, shorter
hospital stay, and lower hospital costs. 
Received 17th March 2005. Accepted for publication in final form 17th
August 2005.
From the Department of Anesthesiology and Critical Care, Medic l
Faculty of Karadeniz, Technical University, Trabzon, Turkey. Address
correspondence and reprint requests to Dr. Ahmet C. Senel,
Department of Anesthesiology and Critical Care, Karadeniz Technical
University Medical School, Trabzon 61080, Turkey. E-mail:
acsenel@hotmail.com
References
  1.Miller RD. Anesthesia: use of sedative-analgesic drugs
during MAC. 5th ed. Pennsylvania (PA): Churchill
Livingstone; 2000. p. 1454-1460.  
  2.Viñuela F, Duckwiler G, Mawad M. Guglielmi detachable
coil embolization of acute intracranial aneurysm:
perioperative anatomical and clinical outcome in 403
patients. J Neurosurg 1997; 86: 475–482. 
O
Endovascular treatment of intracranial aneurysms under sedation
       
        www.smj.org.saSaudi Med J 2005; Vol. 26 (11)   835
alopecia areata, were no different in both obese and
normal BMI adult individuals.
The present study emphasizes the strong
association of skin manifestations and obesity,
which reflects the abnormal metabolism mainly
insulin resistance, and we also found that the
frequency of skin diseases is parallel with the
degree of obesity, especially in children.
Acanthosis nigricans (AN) is a major problem
among obese individuals, and has been reported in
74%.1 The present work showed 59.6% among
children and 72% among adults, while it was absent
in normal weight children, and only 1% in normal
weight adults. It has been suggested that
hyperinsulinemia is a cause of AN by stimulation of
insulin like growth factor 1.2 Also in a recent Iraqi
study, AN has been reported in 68.75% of infertile
females with polycystic ovarian syndrome (PCOS).3
There is a definite association between skin tags and
adult obesity.1 We found skin tags in 13.5% of
obese children, and 58% in obese adults, while it
was absent in normal weight children, and only 30%
in normal weight adults. Obese individuals in both
the children and adult groups, showed increased
prevalence of planter hyperkeratosis; 48.1% in
children and 47% in adult individuals in comparison
with normal weight individuals 2% in children and
9% in adults. Only one study has shown an increase
in planter hyperkeratosis in obese adults.1 This study
shows a striking association between obesity and
striae distensae, both in children and adult
individuals compared to normal BMI children and
adults. These findings are comparable to previous
diagnosis of skin diseases. Table 1 shows the
frequency of skin diseases found in the normal BMI,
overweight and obese children, and we found no
differences between the BMI groups for the
following skin diseases: palmar peeling, pityriasis
alba, macular hypopigmentation, pityriasis
versicolor, and perioral hyperpigmentation.
Part 2: A case series descriptive epidemiological
study conducted at Baghdad, Teaching Hospital,
Department of Dermatology and Venereology,
Baghdad, Iraq from December 2003 to August
2004. We included 100 obese cases; 60 males and
40 females, with an age range of 18-54 years, and
100 normal weight individuals attending the same
department; 60 males and 40 females, as the control
group with the same age range. The frequency of
skin diseases was significantly high (p-value
<0.026-0.00001) in the adult obese group compared
with normal BMI individuals, which included the
following diseases: acanthosis nigricans (72%
versus 1%), planter hyperkeratosis (47% versus
9%), skin tags (58% versus 30%), striae distensae
(33% versus 10%), intertrigo (52% versus 6%),
hyperhidrosis (30% versus 4%), dry skin (23%
versus 10%), and erythrasma (11% versus 3%).
While we found other diseases uch as hirsutism
(20% versus 7.5%), tinea cruris (13% versus 9%),
tinea versicolor (11% versus 7%), boils (8% versus
3%) and warts (8% versus 7%), increased among
obese individuals, but they were not statistically
significant (p-value >0.78-0.05). Other diseases
such as dermatitis, psoriasis, leukonychia, and
Table 1  - Frequency of skin diseases found in normal BMI, overweight and obese children included
in the study.
Acanthosis nigricans
Planter hyperkeratosis
Skin tags
Striae distensae
Intertrigo
Dry skin
Hyperhidrosis
Dermatitis
Common warts
Leukonychia
Angular cheilitis
Skin infections
Impetigo
Boils
Tinea cruris
Tinea versicolor
0
2
0
2
1
3
0
3
1
10  
1
1
26
10
  1
15
  3
12
  1
  6
  2
15
  1
  2
Normal BMI
(0)
(2)
(0)
(2)
(1)
(3)
(0)
(3)
(1)
(10)  
(1)
(1)
Overweight
 (27.65)
(10.6) 
    (1.1)   
 (15.95) 
   (3.2)   
 (12.8)   
(1.1)
   (6.4)   
   (2.1)   
 (15.95) 
   (1.1)   
  (2.1)  
31
25
  7
18
19
24
  6
  6
  2
  8
  3
  2
Obese
(59.6) 
(48)    
 (13.5)  
 (34.6) 
(36.5)
  (46.15)
 (11.5) 
  (11.5)  
  (3.8)
(15.4)
  (5.8)
  (3.8)
Skin diseases Number (%)
0.0000001
0.0000001
0.000016  
 0.0000003 
0.0000001
0.0000001
0.0001      
0.11          
0.49          
0.4            
0.09          
0.49          
Part 1
p values
<0.00001
<0.00001
<0.0001  
<0.00007
<0.00001
<0.01      
 <0.00001 
   
0.78     
0.12     
>0.05       
 0.322    
Part 2
p values
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converting enzyme inhibitors and beta
blockers after acute myocardial
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n recent years, many clinical trials suggested
using certain medications such as beta-blockers
(BB), angiotensin converting enzyme inhibitors
(ACE-I), low dose aspirin, and statins to reduce
morbidity and mortality after acute myocardial
infarction (AMI). Since the 1980s, we have known
the clinical benefits of BB post AMI. Angiotensin
converting enzyme inhibitors are also useful in
managing asymptomatic and symptomatic left-
ventricular dysfunction (LVD), and thus preventing
the development of cardiac remodeling process after
AMI.1 Lipid lowering agents, in particular statins
decrease the risk of coronary events and total
mortality in patients after myocardial infarction.2
Previous randomized trials illustrate the significant
reductions of mortality rate in patients receiving
aspirin for secondary prevention after AMI.3 To
evaluate the impact of these clinical trials and
evidence based medicine on physician practice
pattern, we examined the trends in the use of BB,
ACE-I and other medication therapy in patients
discharged after AMI. We tried to identify clinical
factors associated with ACE-I prescribing patterns.
The data were collected from Al-Watani
Governmental Hospital in Nablus, Palestine from
January to December 2004. The medical files of
patients admitted to the ICU and diagnosed with
AMI were reviewed and analyzed. An ECG,
enzymes, and symptoms confirmed the diagnosis of
AMI. Data obtained from medical files included
age, gender, medical history, blood pressure, heart
rate, myocardial infarction (MI) type and left
ventricular ejection fraction (LVEF). The use of
medications at admission and discharge was also
reports in adults of 42.9%,1 however, there is no
record of striae distensae among obese children.
Previous reports demonstrate intertrigo among
obese individuals,4 and we similarly observed this in
the present work, as we found intertrigo higher n
obese versus normal adult individuals and children.
Dry skin was a common problem found more in the
obese individuals, mainly affecting cheeks, dorsa of
the hands, feet, and legs. This observation was not
noticed before, and we could find no clear
explanation. We found hyperhidrosis high in obese
individuals, when compared to overweight and
normal weight children, and similarly found in adult
obese in comparison with normal weight
individuals. Previous reports confirm this.5   Previous
studies found skin infections, mainly in the form of
boils, wart, tinea cruris, and erythrasma increased
among obese individuals.1 While in the present
work although they did not reach statistically
significant levels, we found more in obese
individuals than normal weight individuals, apart
from erythrasma, which was significantly high in
adult obese individuals. The association between
hirsutism and obesity was not be clear the in
literature, and often hirsutism had been reported to
be high in obese females with PCOS.3 Similarly, in
the present work, although it did not reach a
statistically significant level, we found more in adult
obese females than normal weight females.
The excessive fat deposition that leads to
thickening of the fatty layer all over the body
deserves the term adipomegaly, rather than obesity
as it is more scientific, academic, and more socially
and publically accepted.
In conclusion, skin manifestations are a common
problem, and important markers of obesity
reflecting impaired metabolism, especially
acanthosis nigricans, skin tags, and planter
hyperkeratosis.
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diabetic patients, in patients with history of heart
failure, and in patients with an LVEF less than 40%.
Analyses of medications at discharge showed that
patients prescribed calcium channel blockers or
digoxin were more likely to receive ACE-I therapy
at discharge. In contrast, patients prescribed with
BB were less likely to receive ACE-I therapy at
discharge. Of all the patients included, 129/151
(85.4%) were prescribed with BB at discharge. The
presence of diabetes mellitus (DM) and MI had no
significant effect on prescribing BB. However, BB
prescribing was significantly more common among
patients with an LVEF >40%, in patients with no
heart failure, in patients with high blood pressure
and in patients prescribed with neither CCB nor
ACE-I (Table 1). All patients included were
prescribed with low dose of 100 mg aspirin; none
were prescribed anti-hyperlipidemic statin drugs
while 10/151 (6.6%) patients were prescribed CCB.
Temporal analysis showed that the prescribing of
ACE-I or BB did not change with time during 2004,
suggesting that changes in prescribing pattern are
usually slow throughout the year.
We undertook this study to determine if, in
Palestine, we have practically adopted the established
clinical recommendations and evidence-based
medicine for treatment after MI. We used
physician’s prescribing patterns of ACE-I and BB at
discharge after MI as the main parameter of
assessment, and concluded that there is a low post-
infarction prophylactic used of ACE-I while a high
post-infarction prophylactic used of BB. Unfortunately,
there are no previous studies carried out in Palestine
regarding postinfarction prophylactic drugs to
compare the current data. Although we found BB
obtained. The major dependent variable analyzed n
this study was whether ACE-I or BB was prescr bed
at hospital discharge or not. The clinical factors
associated with ACE-I and BB prescribing were
also analyzed. The other 2 important factors in this
study considered were MI type and LVEF, due to
their important roles in determining appropriate
treatment. All data were analyzed using statistical
package for social sciences (SPSS) version 11. For
statistical significance, chi-square test and cross
tabulation were used.
We identified 174 patients with AMI. Twenty-
three patients (13.2%) died during hospitalization
and were excluded. The mean age of patients was
61.7 years, and the majority was male (72%).
Analysis of risk factors predisposing the patients to
AMI, among the studied sample, showed that more
than half of the patients were men above 60 years
old and mostly smokers. Approximately one-third of
the patients were hypertensive, and 40% were
diabetics. Low dose aspirin and BB were the most
common medication prescribed at discharge. On
admission, approximately 93% of patients were
given both low dose aspirin and heparin as an
anticoagulant. Calcium channel blockers were given
at a higher rate on admission than at discharge (data
not shown). Regarding BB, the rates of prescribing
on admission were 79.5% while at discharge were
85.4%, with no statistical difference. Of all the
patients included, only 22.4% were prescribed
ACE-I at discharge. Neither gender, nor hypertension
or the type of MI has a significant effect on
prescribing ACE-I at discharge. However, ACE-I
prescribing was significantly more common among
BP - blood pressure, DM - diabetes mellitus, LVEF - left ventricular ejection fraction, CHF - congestive heart failure, ACE-I - angiotensin
converting enzyme inhibitors, BB - beta blockers.      
Variable
Table 1  - Influence of various clinical factors on the rate of ACE-I and BB prescribing at discharge after acute myocardial infarction. 
BP                    
High
Normal
DM                 
Yes
No
LVEF          
< 40%
> 40%
CHF                 
Yes
No
ACE-I prescribed at
discharge
(23.5)
(23)   
(37)   
(13.4)
(58.3)
(16.5)
  (4.3)
(17.2)
ACE-I not prescribed
at discharge
(76.4)
(77)   
 (62.9) 
 (86.5) 
(41.6)
(83.5)
(43.5)
(82.8)
BB prescribed at
discharge
(86.3)
(85)   
  (9.7)
(82)   
  (6.7)
(98.4)
(13)   
 (98)    
BB not prescribed at
discharge
(13.7)
(15)   
(90.3)
(18)   
   
(83.3)
  (1.6)
 (87)    
    (1.6)  
12/51  
23/100
23/62  
12/89  
14/24  
 21/127 
13/23 
 22/128 
   39/51   
   77/100 
39/62
 77/89
10/24
106/127
10/23
106/128
44/51 
  85/100 
    6/62  
  73/89   
 4/24
125/127 
 
 3/23
126/128 
7/51
15/100
56/62  
16/89  
  
20/24  
  2/127
 20/23   
  2/128
ACE-I and BB after acute MI
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recommendations of major clinical trials. However,
the post MI prescribing of ACE-I and statins do not
closely follow the publications of major trials.
Focus should be made on the recent updated trials in
pharmacological intervention. Non-pharmacological
counseling for patients is also needed and should be
carried out by clinical pharmacists.
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commonly prescribed after AMI in the studied
sample, generally, under prescription among
patients with MI and heart failure still exists. It is
noteworthy that a high percentage of diabetic
patients received BB after AMI, agreeing with many
studies indicating that BB is more effective in
diabetic patients than non-diabetic patients.1
We cannot explain the low rate of ACE-I
prescribed in the studied patients. It could be that
fear from renal functional problems or potassium
levels, or fears of hypotension discourage
physicians from prescribing ACE-I. Analysis of the
effect of age of patients on ACE-I prescribing
showed that physicians prescribe this class of drug
more commonly to patients above 70 years old
compared with younger ones. Again, this is puzzling
given the fact that the elderly tend to have high r
contraindications to ACE-I than younger patients
due to kidney function. 
All patients in the study were prescribed low dose
aspirin and none were prescribed any other anti-
platelet. Statins were not prescribed despite several
trials showing their effect in decreasing the risk of
coronary events and total mortality in patients after
acute MI. The failure to prescribe statins may be
due to the unavailability of this class of drug in the
hospital. The modern management of patients
following MI rests on lifestyle modifications and
addressing risk factors such as hypertension,
hyperlipidemia, diabetes, and specifically
intervening with medications such as ACE-I, BB,
statins, and aspirin. We found a large percentage of
smokers, and many had other co-morbid conditions
that necessitated aggressive post MI prophylactic
therapy.  Similar studies have taken place in other
countries. One carried out in Denmark, found the
rate of BB prescribed at discharge after AMI was
67.9%, while prescribing of ACE-I was 35.5%.5
Another study carried out in the USA in 1998 found
the rate of ACE-I prescribing nationwide were
30.7% during the year 1996.6 Another study carried
out in the USA in the state of New York in 1999,
found that the ACE-I prescribing rate at discharg
after AMI were 34%.7 A study carried out in Spain
in year 2002 found that the rate of prescribing post
MI of ACE-I was 32.5% and BB was 50.2%.8
In conclusion, we observed that post MI
prescribing of BB and low dose aspirin follows the
ACE-I and BB after acute MI
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